Status:
COMPLETED
Clinical and Molecular Characterization of Cerebral Proliferative Vasculopathy
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Proliferative Vasculopathy
Eligibility:
All Genders
Brief Summary
As principal objective, the study aims to: 1. Describe the spectrum and evaluate the frequency of angiodysplasia of the nevrax; 2. Establish the physiopathological basis of Fowler's syndrome; 3. Iden...
Eligibility Criteria
Inclusion
- Angiodysplasia restricted to central nervous system with or without glomerular vasculopathy.
- Informed consent signed.
Exclusion
- Vascular malformations not confined to the nevrax.
- No signature of consent.
Key Trial Info
Start Date :
July 8 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 6 2016
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03293134
Start Date
July 8 2013
End Date
October 6 2016
Last Update
September 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Necker Enfants Malades, APHP
Paris, France, 75006